--- title: "(NU/1433-33) GitLife Biotech: providing a lab-in-the-cloud versioning control system for engineered cell lines. Commercialisation of university research through provision of management skills to assist in successful spin-out company creation and scale-up" ocid: "ocds-h6vhtk-0354ac" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0354ac" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0354ac.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0354ac.json" source: "Find A Tender Service" current_stage: "Award" buyer: "NEWCASTLE UNIVERSITY" published: "2022-07-22" --- # (NU/1433-33) GitLife Biotech: providing a lab-in-the-cloud versioning control system for engineered cell lines. Commercialisation of university research through provision of management skills to assist in successful spin-out company creation and scale-up Buyer: NEWCASTLE UNIVERSITY Current stage: Award OCID: ocds-h6vhtk-0354ac [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0354ac) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0354ac.json) ## Summary The public procurement process involved Newcastle University as the buying organisation, seeking to appoint a CEO (Designate) for the spin-out company GitLife Biotech, associated with a project that aims to develop a cloud-based version control system for engineered cell lines. This tender was classified under the services industry, specifically in business and management consultancy, with contracts awarded on 23rd June 2022. The procurement method employed was selective, following a restricted procedure. The tender was ultimately completed, with an active contract valued at £29,760. This tender presents an excellent opportunity for growth, particularly for businesses specialising in executive search, venture capital, or business consultancy within the biotech and life sciences sectors. Companies that have experience in managing start-ups, particularly those with a focus on deeptech or university spin-outs, will find themselves well-placed to compete for this contract. The involvement of seasoned professionals with strong networks in investment and commercialisation will be crucial in capitalising on this opportunity. ## Notice Professor Krasnogor saw an opportunity in developing a solution to the "Integration" problem that is generic for biotechnology and the life sciences beyond the specifics of these two projects. This is how the idea of establishing GitLife Biotech and the development of the CellRepo technology, as a versioning control system for engineered cell lines, including biotechnology microorganisms, in the cloud was born. The plan is to spin out GitLife Biotech Ltd in Q3 2022. To be able to spin out and take forward this opportunity, securing the involvement of experienced and appropriate business leadership is both essential and complementary to the existing technical staff and resource. Commercial and business skills are needed in addition to those in the current team. Moreover, it is clearly the case that Prof. Krasnogor and the current team will need to remain focused on the scientific and technical aspects of the company and be able to place trust in and be guided by experienced staff (ideally with sector experience, networks and VC contacts) who will run the day-to-day business operations and company's strategic development. Thus, a talented and experienced CEO (Designate) to assist in the development of the business plans and forecasting needed to spin out the company from the University, as well as to provide leadership of GitLife Biotech, is needed. The person appointed to lead the company formation and development will have experience in business start -ups, deeptech companies or University Spin Outs, marketing, innovation and fund raising. ### Lot Information Lot 1 Professor Krasnogor saw an opportunity in developing a solution to the "Integration" problem that is generic for biotechnology and the life sciences beyond the specifics of these two projects. This is how the idea of establishing GitLife Biotech and the development of the CellRepo technology, as a versioning control system for engineered cell lines, including biotechnology microorganisms, in the cloud was born. The plan is to spin out GitLife Biotech Ltd in Q3 2022. To be able to spin out and take forward this opportunity, securing the involvement of experienced and appropriate business leadership is both essential and complementary to the existing technical staff and resource. Commercial and business skills are needed in addition to those in the current team. Moreover, it is clearly the case that Prof. Krasnogor and the current team will need to remain focused on the scientific and technical aspects of the company and be able to place trust in and be guided by experienced staff (ideally with sector experience, networks and VC contacts) who will run the day-to-day business operations and company's strategic development. Thus, a talented and experienced CEO (Designate) to assist in the development of the business plans and forecasting needed to spin out the company from the University, as well as to provide leadership of GitLife Biotech, is needed. The person appointed to lead the company formation and development will have experience in business start -ups, deeptech companies or University Spin Outs, marketing, innovation and fund raising. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/019972-2022 | | Notice type | Award Notice | | Procurement type | Dynamic | | Procurement category | Services | | Procurement method | Selective | | Procurement method details | Restricted procedure | | Tender suitability | Not specified | | Awardee scale | SME | | All stages | Award | ## Dates | Field | Value | | --- | --- | | Publication date | 22 Jul 2022 | | Submission deadline | Not specified | | Future notice date | Not specified | | Award date | 22 Jun 2022 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | £29,760 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | NEWCASTLE UNIVERSITY | | Additional buyers | DURHAM UNIVERSITY; EUROPEAN UNION; NORTHUMBRIA UNIVERSITY NEWCASTLE; TEESSIDE UNIVERSITY; UNIVERSITY OF BATH ON BEHALF OF THE SETSQUARED; UNIVERSITY OF SUNDERLAND | | Locality | NEWCASTLE | | Post town | Newcastle upon Tyne | | Postcode | NE1 7RU | | Country | England | | ITL 1 | TLC North East (England) | | ITL 2 | TLC4 Northumberland, Durham and Tyne & Wear | | ITL 3 | TLC43 Tyneside | | Local authority | Newcastle upon Tyne | | Electoral ward | Monument | | Westminster constituency | Newcastle upon Tyne Central and West | | Delivery location | TLC North East (England) | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 1 | | Supplier names | CAMBRIDGE FUTURE TECH | ## CPV Codes ### Divisions - 79 - Business services: law, marketing, consulting, recruitment, printing and security ### Codes - 79400000 - Business and management consultancy and related services ## Release History - 22 Jul 2022 at 08:59 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/019972-2022 ## Notice URLs - https://Sunderland.ac.uk - https://northumbria.ac.uk - https://ted.europa.eu/udl?uri=TED:NOTICE:016574-2019:TEXT:EN:HTML - https://www.bath.ac.uk/ - https://www.durham.ac.uk - https://www.ncl.ac.uk - https://www.tees.ac.uk/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0354ac. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0354ac.json.